DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 158 filers reported holding DIPLOMAT PHARMACY INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,994,000 | +18.7% | 154,294 | +56.4% | 0.02% | +6.2% |
Q2 2018 | $2,522,000 | +33.1% | 98,657 | +4.9% | 0.02% | +14.3% |
Q1 2018 | $1,895,000 | -0.8% | 94,047 | -1.2% | 0.01% | -6.7% |
Q4 2017 | $1,910,000 | -3.1% | 95,169 | +0.0% | 0.02% | -16.7% |
Q3 2017 | $1,971,000 | +38.0% | 95,161 | -1.4% | 0.02% | +28.6% |
Q2 2017 | $1,428,000 | +173.6% | 96,522 | +194.9% | 0.01% | +133.3% |
Q1 2017 | $522,000 | +55.8% | 32,735 | +23.1% | 0.01% | +50.0% |
Q4 2016 | $335,000 | -63.0% | 26,598 | -17.7% | 0.00% | -63.6% |
Q3 2016 | $905,000 | -21.6% | 32,304 | -2.2% | 0.01% | -35.3% |
Q2 2016 | $1,155,000 | +25.5% | 33,024 | -1.6% | 0.02% | +13.3% |
Q1 2016 | $920,000 | -21.0% | 33,565 | -1.4% | 0.02% | -21.1% |
Q4 2015 | $1,165,000 | – | 34,030 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |